The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - MD Anderson Cancer Center
Travel, Accommodations, Expenses - Amgen Astellas BioPharma; Celgene; Merck Sharp & Dohme; Novartis Pharmaceuticals UK Ltd.
Outcomes in men with metastatic castrate-resistant prostate cancer treated with early platinum-based chemotherapy following an unsatisfactory response to androgen receptor (AR) inhibition as part of the phase II dynamic allocation modular sequential (DynAMo) trial.
 
Paul Vincent Viscuse
No Relationships to Disclose
 
Miao Zhang
No Relationships to Disclose
 
Jingjing Liu
No Relationships to Disclose
 
Rebecca Tidwell
Research Funding - Galera Therapeutics (Inst)
 
Sumit Kumar Subudhi
Stock and Other Ownership Interests - Apricity Health
Honoraria - Amgen; Apricity Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Dava Oncology; Dendreon; Exelixis; Janssen; Parker Institute for Cancer Immunotherapy; Polaris; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Amgen; Apricity Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Dava Oncology; Dendreon; Janssen; Polaris; Valeant/Dendreon
Research Funding - AstraZeneca; Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Compugen; Dava Oncology; Dendreon; Janssen; Parker Institute for Cancer Immunotherapy; Society for Immunotherapy of Cancer
 
Amado J. Zurita
Honoraria - Exelixis; Janssen Oncology; Pfizer
Consulting or Advisory Role - Exelixis
Research Funding - Infinity Pharmaceuticals; Pfizer
 
Paul G. Corn
Research Funding - Janssen Oncology (Inst)
 
Shi-Ming Tu
Consulting or Advisory Role - Janssen Biotech
 
John C. Araujo
Employment - MD Anderson Cancer Center
Honoraria - Bayer; Incyte; Janssen
Research Funding - Bayer; Incyte; Janssen
Travel, Accommodations, Expenses - Bayer; Incyte; Janssen
 
Jennifer Wang
No Relationships to Disclose
 
Eleni Efstathiou
Employment - MD Anderson Cancer Center
Honoraria - Astellas Oncology; Bayer; Janssen; Sanofi; Tolmar
Consulting or Advisory Role - Astellas Oncology; Bayer; Janssen; Sanofi; Tolmar
Research Funding - Astellas Oncology; Bayer; Janssen; Sanofi; Tolmar
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; Janssen; Sanofi; Tolmar
 
Jianbo Wang
No Relationships to Disclose
 
Patrick Glen Pilie
Patents, Royalties, Other Intellectual Property - Patent Pending- biomarker
 
Patricia Troncoso
Employment - MD Anderson Cancer Center
 
Jianhua Zhang
Employment - MD Anderson Cancer Center
 
Christopher Logothetis
Honoraria - Amgen; Bayer; Exelixis; Merck Sharp & Dohme
Consulting or Advisory Role - Amgen; Bayer; Exelixis; Merck Sharp & Dohme
Research Funding - Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Sanofi
 
Ana Aparicio
Honoraria - Biosense Webster (I); Boston Scientific (I); Genzyme
Consulting or Advisory Role - American Cancer Society; American Cancer Society; Biosense Webster (I); Boston Scientific (I); Janssen Research & Development
Speakers' Bureau - Biosense Webster (I); Boston Scientific (I)
Research Funding - BioSense Webster (I); Boston Scientific (I); Bristol-Myers Squibb (Inst); Hansen Medical (I); Janssen (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Two (I)
Travel, Accommodations, Expenses - Biosense WEbster (I)